23.9 C
New York
Thursday, June 18, 2026

Tag: union

newssourceFORcompanyinformationcontent1marketreleases

ESTUARY POWER COMMENCES OPERATION OF ESCAPE SOLAR AND STORAGE PROJECT AND CLOSES ADDITIONAL FINANCING

RENO, Nev., July 22, 2025 /PRNewswire/ -- Estuary Power is delighted to announce the commencement of operations of its Escape Solar and Storage project in...

Transaction in Own Shares

Transaction in Own Shares

LEPF PRAISES LEADERSHIP OF SENATORS, SECRETARY RUBIO, AND PRESIDENT TRUMP ON ISSUE IMPACTING AIR TRAVEL SAFETY

Letter to Secretary of State Rubio by Senators Blackburn, Thune, and Kelly and President's Appointment to Vacant Ambassador Position Spotlights Experienced Pilots and US...

Tariff Rates Skyrocket—Economists Finally Discover Gravity

President Trump, the self-proclaimed "tariff man," seems to have a peculiar hobby: reviving relics of past economic blunders by advocating for tariffs reminiscent of...

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil®...

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil®...

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

CHAMPION IRON ENTERS INTO A DEFINITIVE AGREEMENT WITH NIPPON STEEL AND SOJITZ TO FORM A PARTNERSHIP FOR THE KAMI PROJECT

MONTRÉAL, July 21, 2025 /CNW/ - SYDNEY, July 22, 2025 - Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") announces...

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Transaction in Own Shares

Transaction in Own Shares

NYSE Content Advisory: Pre-Market update + FIFA World Cup 2026 NY/NJ Host Committee to ring the opening bell

NEW YORK, July 21, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor....

NYSE Content Advisory: Pre-Market update + FIFA World Cup 2026 NY/NJ Host Committee to ring the opening bell

NEW YORK, July 21, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsUnion

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers